Finance

Beta
Lists
GBLX:OTCMKTS
GB Sciences Inc
$0.00030
0.00%
(0.00) 1D
Jul 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GBLX...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
122.12K
Avg. vol.
28.12K
Volume
1.15K
52-wk high
$0.50
52-wk low
$0.00
Beta
0.94
Shares outstanding
407.07M
No. of employees
2
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
122.12K
Avg. vol.
28.12K
Volume
1.15K
52-wk high
$0.50
52-wk low
$0.00
Beta
0.94
Shares outstanding
407.07M
No. of employees
2
News stories
From sources across the web
About GB Sciences Inc
CEO-
Employees2
FoundedApr 4, 2001
HeadquartersLas Vegas, Nevada, United States
SectorPharmaceutical industry
Websitegbsciences.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2024
Sep 2024
Dec 2024
Revenue
-
-
97.24K
Cost of goods sold
-
-
-
Cost of revenue
-
-
-
Research and development expenses
-
-
-
Total research and development expenses
-
-
-
Selling, general, and admin expenses
254.14K
157.79K
163.83K
Operating expense
254.14K
157.79K
163.83K
Total operating expenses
254.14K
157.79K
163.83K
Operating income
-254.14K
-157.79K
-66.59K
Other non operating income
-
-
-
EBT including unusual items
-285.02K
-190.53K
-100.36K
EBT excluding unusual items
-285.02K
-190.53K
-100.36K
Income tax expense
-
-
-
Effective tax rate
-
-
-
Other operating expenses
-
-
-
Net income
-285.02K
-190.53K
-100.36K
Net profit margin
-
-
-103.21%
Earnings per share
-
-
-
Interest and investment income
-
-
-
Interest expense
-30.88K
-32.74K
-33.76K
Net interest expenses
-30.88K
-32.74K
-33.76K
Depreciation and amortization charges
-
-
-
EBITDA
-253.98K
-157.63K
-66.44K
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer